Informed Decisions: Dialogue with Treatment-Naïve Pregnant Patients Regarding Systemic Atopic Dermatitis Treatment Options
Focusing on pregnant patients with atopic dermatitis who are treatment naïve, Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, discuss best practices for informing patients on the available treatment options for this condition.
Insights on Transcription Binding in Atopic Dermatitis
Jenny Murase, MD, provides a brief overview of the Fc receptor and the role of transcription binding in atopic dermatitis.
Navigating Treatment Choices: Balancing Treatment Options for Childbearing-Age Patients
Dermatologists provide clinical insights on how they discuss atopic dermatitis treatment options, considerations, and safety concerns with patients who are pregnant or of childbearing age.
Exploring Changes in Atopic Dermatitis Severity Across the Pregnancy Journey
Jenny Murase, MD, describes how rising estrogen levels cause a shift in immune response from Th1 to Th2, causing potential atopic dermatitis exacerbations for patients who are pregnant.
Fostering Communication: Promoting Dialogue on Atopic Dermatitis Treatment Concerns in Patients of Childbearing Potential
Experts on atopic dermatitis discuss the importance of open dialogue with patients who are pregnant or of childbearing potential regarding the safety concerns associated with treatments for this condition.
Unveiling Treatment Gaps: Expert Perspectives on the Undermanagement of Patients with Atopic Dermatitis and Childbearing Potential
Dr. Elizabeth Kiracofe, MD, FAAD, and Dr. Jenny Murase, MD, introduce a discussion on the undertreatment of patients with atopic dermatitis, particularly focusing on pregnant individuals and those of childbearing age.
Navigating Delusional Infestations in Dermatology
Jenny Murase, MD, said the average dermatologist manages 2-3 patients with delusional infestations every 5 years. Learn what to expect and how to manage it with empathy.
